Adoptive Transfer of Chimeric Antigen Receptor Re-directed Cytolytic T Lymphocyte Clones in Patients with Neuroblastoma-Reference-Cited by-同舟云学术

Adoptive Transfer of Chimeric Antigen Receptor Re-directed Cytolytic T Lymphocyte Clones in Patients with Neuroblastoma

Published:2007-04 Issue:4 Volume:15 Page:825-833
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Park Julie R,DiGiusto David L,Slovak Marilyn,Wright Christine,Naranjo Araceli,Wagner Jamie,Meechoovet Hunsar B,Bautista Cherrilyn,Chang Wen-Chung,Ostberg Julie R,Jensen Michael C

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference28 articles.

1. Production and characterization of monoclonal antibodies against human neuroblastoma;Schonmann;Int J Cancer,1986

2. A comparison of targeting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients;Hoefnagel;Eur J Nucl Med,2001

3. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers;Gavert;J Cell Biol,2005

4. Gene expression of neural cell adhesion molecule L1 in malignant gliomas and biological significance of L1 in glioma invasion;Izumoto;Cancer Res,1996

5. Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma;Thies;Eur J Cancer,2002

Cited by 514 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing Chimeric Antigen Receptor-engineered Invariant Natural Killer T Cells: Therapeutic Strategies for Cancer and the Tumor Microenvironment;Current Pharmaceutical Biotechnology;2024-11

2. Recent Advancements in Cell-Based Therapies in Melanoma;International Journal of Molecular Sciences;2024-09-12

3. CAR-T: from bench to bedside;Oncohematology;2024-09-03

4. Chick Embryo Chorioallantoic Membrane as a Platform for Assessing the In Vivo Efficacy of Chimeric Antigen Receptor T-cell Therapy in Solid Tumors;ImmunoHorizons;2024-08-01

5. Current Strategies to Improve Chimeric Antigen Receptor T (CAR-T) Cell Persistence;Cureus;2024-07-24